Vous êtes sur la page 1sur 2

REVENUE at ` 165.7 Mn, Up by 7.

6%
EBITDA at ` 42.3 Mn, Margin of 25.6%
PAT at ` 14.6 Mn, up by 114%
August 12, 2015, Delhi: Sunil Healthcare Ltd, a leading manufacturer of Empty Hard Gelatin
Capsules, has announced its Un-audited Financial Results for the quarter ended 30th June
2015.
Key Financial Highlights :
` Million

Q1FY16

Q1FY15

YoY%

Revenue

165.7

154.0

7.6%

EBITDA

42.3

29.8

41.9%

EBITDA Margin

25.6%

19.4%

620 bps

Profit Before Tax

24.8

11.8

111.0%

PAT

14.6

68.0

113.9%

PAT Margin

8.8%

4.4%

440 bps

Cash PAT

23.6

19.3

21.9%

14.2%

12.5%

170 bps

Cash PAT Margin

Performance Highlights:
Revenues for the quarter stood at ` 165.7 mn, recording a 7.6% growth YoY. EBIDTA for the
quarter was at ` 42.3 mn, and EBITDA margins stood at 25.6%, an expansion of 620 bps YoY.
Net Profit After Tax was at ` 14.6 mn, growth of 113.9% over Q1 FY15. PAT margin was at
8.8%, an expansion of 440 bps YoY. Cash PAT margin came in at 14.2% an improvement of
170 bps YoY.
Commenting on the results, Mr. D. Gnanasekaran (CEO) said We are happy to report strong
quarterly performance, which sees a growth of 7.6 % in our top line, and 41.9 % in EBITDA.
Our rigorous focus on delivering on key customers matrix has enabled us to build on new
customers in domestic and international markets, bringing new geographies under our
umbrella.

Brownfield Expansion for Capsules:


The quarter saw further progress on the expansion phase. The additional capacity of 2.3
billion capsules p.a. will be installed in Q2 of this year, taking the total capacity to 10 billion
capsules p.a at the same location - Alwar, Rajasthan.
We are on course towards completion of our expansion phase within Q2FY16, which should
enable us to cater to the increasing demand requirement. It may be worth noting that we are
completing this expansion within the existing infrastructure of land and other utilities
thereby, achieving economies of scale. With the expansion coming downstream soon, we
expect the benefits of the increased capacity to kick in from the 3rd quarter.
It is a fast growing industry. We being one of the market leaders, look forward to the
opportunities in the domestic and overseas markets and are well geared to take the company
forward in its growth trajectory.
About Sunil Healthcare Ltd
Sunil Healthcare Ltd, is the second largest manufacturer of Empty Hard Gelatin Capsules in
India. A GoI recognized Star Export House, ~50% of revenues are from exports. With four
decades of experience, and a strong brand equity Sunloc, the company is a preferred vendor
for large pharmaceutical companies.
The company was the pioneer of Double lock and Triple lock technology in India. With a strong
focus on R &D, the company is constantly innovating its product line to cater to the industry
requirements.
For more information, please visit the company website www.sunilhealthcare.com
Safe harbor statement
Statements in this document relating to future status, events, or circumstances, including but not limited to
statements about plans and objectives, the progress and results of research and development, potential project
characteristics, project potential and target dates for project related issues are forward-looking statements
based on estimates and the anticipated effects of future events on current and developing circumstances. Such
statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results.
Actual results may differ materially from those anticipated in the forward-looking statements. The company
assumes no obligation to update forward-looking statements to reflect actual results changed assumptions or
other factors.

For Further Details, Please Contact:


Company :
Sunil Healthcare Ltd.
CIN - L24302DL1973PLC189662
Mr. Pawan Rathi, Chief Financial Officer
cfo@sunilhealthcare.com
www. sunilhealthcare.com

Investor Relations Advisors :


Strategic Growth Advisors Pvt. Ltd.
CIN - U74140MH2010PTC204285
Ms. Shefali Dabral / Mr. Arpit Gandhi
+91 9821724042 / +91 9819614277
dshefali@sgapl.net / garpit@sgapl.net
www.sgapl.net

Vous aimerez peut-être aussi